Brief: Titan Pharmaceuticals Announces Pricing Of $5.5 Mln Registered Direct And Pipe Offering Priced At-The-Market

Titan Pharmaceuticals

02/02/2022 13:54

Feb 2 (Reuters) - Titan Pharmaceuticals Inc  TTNP.O :
    * TITAN PHARMACEUTICALS ANNOUNCES PRICING OF $5.5 MILLION
REGISTERED DIRECT AND PIPE OFFERING PRICED AT-THE-MARKET
    * TITAN PHARMACEUTICALS - ENTERED SECURITIES PURCHASE
AGREEMENT
WITH A SINGLE INSTITUTIONAL INVESTOR TO PURCHASE 3.4 MILLION
SHARES OF ITS COMMON STOCK
    * TITAN PHARMACEUTICALS - AGREED TO ISSUE AND SELL TO
INVESTOR 1.3
MILLION PRE-FUNDED WARRANTS, AT SAME PURCHASE PRICE AS IN
REGISTERED DIRECT OFFERING
    * TITAN PHARMACEUTICALS INC - COMBINED OFFERING PRICE OF
EACH
SHARE OR PRE-FUNDED WARRANT AND EACH WARRANT WILL BE $1.18

Source text for Eikon:  ID:nPn8dsrcSa 
Further company coverage:  TTNP.O 

 ((reuters.briefs@thomsonreuters.com;))